Dive into Regeneron’s history of scientific innovation and its mission to improve the lives of patients. Learn about our decades of milestones and achievements.

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. [2]

Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, almost all of which were homegrown in our laboratories.

A complete timeline of Regeneron's History from founding to present including key milestones and major events.

Nov 21, 2024 · Regeneron was founded in 1988 by Leonard Schleifer and George Yancopoulos. Key innovations include the development of monoclonal antibodies and the creation of the VelociGene technology. Regeneron has expanded its operations globally, with offices and facilities in multiple countries.

Regeneron Pharmaceuticals, Inc., founded in 1988 and based in Westchester County, New York, is an American biotechnology company. Initially focused on neurotrophic factors and their regenerative properties, the company's research expanded to encompass cytokine and tyrosine kinase receptors.

Discover historical prices for REGN stock on Yahoo Finance. View daily, weekly or monthly format back to when Regeneron Pharmaceuticals, Inc. stock was issued.

Regeneron’s history spans over 35 years of a relentless focus to invent, develop and commercialize life-transforming medicines for people with serious diseases.

Historical daily share price chart and data for Regeneron Pharmaceuticals since 1991 adjusted for splits and dividends.

Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.